Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BNR CNSX:VCT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBNRBurning Rock Biotech$4.83+4.3%$3.17$2.18▼$7.90$51.97M0.7523,516 shs18,266 shsVCTVelocity DataC$0.00C$0.00▼C$0.15N/AN/AN/AN/AThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBNRBurning Rock Biotech+10.11%+31.35%+20.89%+57.48%-26.04%VCTVelocity Data0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBNRBurning Rock Biotech1.4745 of 5 stars0.04.00.00.03.31.70.6VCTVelocity DataN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBNRBurning Rock Biotech 0.00N/AN/AN/AVCTVelocity Data 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBNRBurning Rock Biotech$70.67M0.74N/AN/A$7.39 per share0.65VCTVelocity DataN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBNRBurning Rock Biotech-$47.49M-$1.89N/A∞N/A-45.41%-38.33%-25.34%8/28/2025 (Estimated)VCTVelocity DataN/AN/A0.00N/AN/AN/AN/AN/AN/ALatest LXS, JMAT, CRDA, BNR, and VCT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/6/2025Q1 2025BNRBurning Rock BiotechN/A-$0.17N/A-$0.17N/A$18.34 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBNRBurning Rock BiotechN/AN/AN/AN/AN/AVCTVelocity DataN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBNRBurning Rock BiotechN/A3.022.76VCTVelocity DataN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBNRBurning Rock Biotech30.03%VCTVelocity DataN/AInsider OwnershipCompanyInsider OwnershipBNRBurning Rock Biotech30.30%VCTVelocity DataN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBNRBurning Rock Biotech1,39010.76 million7.50 millionNot OptionableVCTVelocity DataN/AN/AN/ANot OptionableLXS, JMAT, CRDA, BNR, and VCT HeadlinesRecent News About These CompaniesVelocity and VCT to address double enrolment challenge in clinical trialsJanuary 31, 2025 | msn.comVelocity Clinical Research Partners with Verified Clinical Trials to combat double enrollment problem in clinical trialsJanuary 30, 2025 | finance.yahoo.comEmcore Rallies After Velocity One Buyout Deal -- UpdateNovember 8, 2024 | marketwatch.comEmcore Shares Rally After Velocity One Buyout DealNovember 8, 2024 | marketwatch.comVelocity MSC Achieves SOC 2 Type II Attestation Certification Reinforcing Dedication to Data Security and Corporate GovernanceOctober 21, 2024 | tmcnet.comPwC: data is the core ingredient for new business initiativesOctober 17, 2024 | dcvelocity.comDBusinesses thrive with real-time data flowsOctober 16, 2024 | dcvelocity.comDNeural networks boost fusion research with rapid ion temperature and rotation velocity predictionsOctober 9, 2024 | msn.comTelemetry Pipelines: Why Data Automation Is The Achilles Heel Of Observability, Security And Digital TwinsOctober 7, 2024 | forbes.comInnovations in Real-Time Data Warehousing: Speed, Scalability, and Predictive InsightsOctober 6, 2024 | techbullion.comTAuthenticID Releases Velocity Checks to Address High-Frequency Fraud AttemptsOctober 3, 2024 | valdostadailytimes.comVVelocity Expands 'POTS IN A BOX' Portfolio with DataRemote’s 5G POTS Replacement SolutionOctober 3, 2024 | thefastmode.comTCSI acquires deposit, overdraft manager specialist VelocitySeptember 21, 2024 | lanereport.comLHenry Boot And 2 Other Stocks On UK Exchange Estimated To Be Trading Below Fair ValueSeptember 18, 2024 | finance.yahoo.com(VEL) Technical DataSeptember 13, 2024 | news.stocktradersdaily.comN3 UK Stocks Estimated To Be Trading At Up To 44.5% Below Intrinsic ValueSeptember 12, 2024 | finance.yahoo.comIDC Launches IDC Velocity for SalesSeptember 11, 2024 | destinationcrm.comDThe Velocity Profits Reviews (2024) by OnlineCOSMOS Affiliate Marketing ExpertSeptember 11, 2024 | techbullion.comTUnlock Financial Success with Velocity Profits: Does It Deliver on Its Promises?September 4, 2024 | bellevuereporter.comBAIT Worldwide launches internal AI & data science teamAugust 31, 2024 | dcvelocity.comDMedia Sentiment Over TimeLXS, JMAT, CRDA, BNR, and VCT Company DescriptionsBurning Rock Biotech NASDAQ:BNR$4.83 +0.20 (+4.32%) As of 12:41 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. In addition, the company provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients. Further, it has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. Additionally, the company offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited was incorporated in 2014 and is headquartered in Guangzhou, China.Velocity Data CNSX:VCTVelocity Data Inc. does not have significant operations. Previously it was engaged in the sale of computer systems and related components primarily to government contractors and federal government end-users in the United States. The company was founded in 1989 and is based in Vancouver, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVDA Greenlight: China H20 Sales Spark 50% Rally Potential New Catalyst Sends Joby Stock to 52-Week Highs Palantir Gets Price Hike From Wedbush Amid High Valuation Insider Selling Hits Market Leaders—Should You Be Worried? MP Materials Stock Booms on New Government Positioning Tilray Shares Blazing: What's Behind the 55% Rally This Month? Will Dollar Tree Break Out After a New $2.5 Billion Buyback? The Reason Analysts Are Bullish on Bloom Energy Stock Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
